Skip to main content

Resource Library

The Resource Library is a compendium of consent forms, risk management recommendations, sample documents, articles, and other risk management materials to promote ophthalmic patient safety and reduce liability. Contact riskmanagement@omic.com with questions.
Found 66 resources.
Feb 21, 2023 | Recommendation
This risk management document presents suggestions to increase patient safety and decrease the likelihood of lawsuits related to these drugs. It also provides information about our sample consent documents for anti-VEGF agents.
Apr 21, 2026 | Consent Form
Apr 21, 2026 | Consent Form
Mar 19, 2023 | Consent Form
Mar 19, 2023 | Consent Form
Aug 9, 2024 | Recommendation
Disclosure of an adverse event or unanticipated outcome is important for patient safety, patient trust, patient right to autonomy to make decisions about treatment, continuity of care among providers, and to provide empathy.
Jun 4, 2025 | Recommendation
Inadequate or improper documentation in medical records can lead to significant risks, including legal liability, compromised patient care, regulatory non-compliance, and financial penalties.
May 26, 2026 | Bulletin
Telephone screening is often the first point of clinical decision making. Poor handling can lead to delayed treatment, patient harm, and significant malpractice liability. Non-physician staff must follow structured protocols and avoid making independent clinical judgments.
Aug 12, 2023 | Article
OMIC has published two reports of endophthalmitis claims studies, one in 2006 and another in 2017. This issue of the Digest updates those studies with data from OMIC’s endophthalmitis claims closed between January 2018 and December 2022, thereby creating a complete analysis of endophthalmitis claims experience from the time of OMIC’s founding in 1987 through 2022.
Oct 10, 2024 | Case Study
Use of excess gas cases usually have devastating visual outcomes and often result in expensive settlements.
Apr 22, 2026 | Consent Form
Oct 25, 2023 | Consent Form
Jul 13, 2017 | Recommendation
Here are some risk management recommendations to help you and your staff members prevent and better respond to the risks of the procedure. Issues addressed in Fluorescein Angiography Recommendations and Consent include delegation of tasks, informed consent, emergency response equipment, and management of complications.
Feb 9, 2026 | Bulletin
Ophthalmology and optometry involve eye conditions and treatments that make strong health literacy especially important.
Nov 10, 2023 | Consent Form
Aug 15, 2024 | Case Study
By Ryan M. Bucsi, OMIC Claims Manager
Stress of litigation can be overwhelming. The first case settled at the insured's request because he could not bear the stress of a potential trial. The second case also settled after the insured took a medical leave due partially to the stress of litigation.
Oct 10, 2024 | Article
This edition of the Digest reports the analysis of closed claims between 1/1/2009 and 12/31/2022 involving the administration of the incorrect type and concentration of gas, which are considered Never Events.
Jan 20, 2025 | Recommendation
Patient noncompliance or nonadherence to treatment recommendations can result in patient safety concerns and potential liability risks for the physician and practice. This noncompliance toolkit discusses the issues and provides sample letters.
Mar 12, 2026 | Bulletin
In malpractice litigation, incomplete or poorly constructed documentation is often cited as evidence of substandard care. Clear, detailed notes help demonstrate sound clinical judgment and adherence to standards of care. Learn best practices for documenting differential diagnoses.
Aug 1, 2024 | Bulletin
We would like to provide you with an update on the use of biosimilars to treat ROP.
Apr 11, 2026 | Article
This document summarizes the conditions of coverage that appear in the ROP application; see that application for a complete discussion of the requirements.
Apr 1, 2022 | Sample Letter/Form/Protocol
Notify parents/caregivers of the need for ongoing ROP exams following discharge from the hospital.
Apr 1, 2022 | Recommendation
This ROP Safety Net Toolkit addresses hospital-based ROP care when treatment will be provided elsewhere. It contains sample protocols, which may need to be customized, and refers to ROP clinical care guidelines.
Apr 1, 2022 | Recommendation
This ROP Safety Net Toolkit addresses screening and treatment in the hospital. It contains sample protocols, which may need to be customized, and refers to ROP clinical care guidelines.
Mar 10, 2022 | Recommendation
Concerns about IVAV both as primary or salvage therapy have been addressed in the literature and at eye society meetings. In addition, many questions are currently being studied and debated. Despite these uncertainties, when faced with aggressive or refractive ROP, ophthalmologists at times feel there is no other prudent choice but to treat ROP with IVAV. This document will address those concerns, and provide risk management recommendations specific to the use of anti-VEGF agents “off-label” for the treatment of ROP.
Apr 1, 2022 | Sample Letter/Form/Protocol
Follow up on all missed, cancelled, or rescheduled ROP appointments, including no-shows, and send this letter if unable to reach the parents to schedule the exam.
Apr 1, 2022 | Recommendation
This ROP Safety Net Toolkit addresses ROP care provided on an outpatient basis. It contains sample protocols, which may need to be customized, and refers to ROP clinical care guidelines.
Apr 1, 2022 | Sample Letter/Form/Protocol
Complete and sign this letter after the first outpatient ROP exam.
Jun 18, 2024 | Sample Letter/Form/Protocol
The protocol listed in these materials is based on the Policy Statement "Screening Examination of Premature Infants for Retinopathy of Prematurity" and the Joint Technical Report "Telemedicine for Evaluation of ROP." The protocol incorporates both required conditions of coverage with OMIC as well as risk management recommendations.
Scroll to top